Edward A. Gardner
Papers
1
Total Citations
30
H-Index
1
About
Edward A. Gardner is a pioneering figure in the field of stereotactic arrhythmia radioablation (STAR), a groundbreaking intersection of radiation oncology and cardiology. His key research areas focus on the non-invasive treatment of cardiac arrhythmias, particularly ventricular tachycardia (VT), using advanced radiosurgical techniques. Gardner’s major contribution lies in demonstrating the feasibility and dosimetric optimization of STAR, as evidenced by his seminal 2016 treatment planning study, which has garnered 30 citations. This work, stemming from the first-ever STAR procedure delivered at Stanford in 2012 on a CyberKnife® robotic radiosurgery system, established critical benchmarks for target delineation and dose delivery. By comparing three distinct treatment approaches, Gardner provided the foundational framework that has enabled subsequent clinical adoption and refinement of this life-saving modality. His research has directly influenced the development of non-invasive alternatives to catheter ablation, offering hope to patients with refractory VT. Gardner’s achievements represent a paradigm shift in arrhythmia management, merging precision radiotherapy with cardiac electrophysiology to create a novel, high-impact therapeutic pathway.
Research Focus
Key Achievements
Top Papers
- 1